NeuBase Therapeutics Inc (NASDAQ:NBSE) gain 29.57% – Is It right time to buy?

NeuBase Therapeutics Inc (NBSE) saw an uptrend of 29.57% in the recent trading with $0.92 being its most recent. The current price level -82.91% lower than the highest price of $5.40 marked by the stock while trading over the past 52-weeks, whereas it is 56.41% higher than the lowest price of $0.59 the company dropped […]